Concepedia

Anil K. Kamaraju

AK

9

Publications

1.7K

Citations

9

H-Index

2002

Active since

Affiliations

National Institutes of Health(Current)

National Institute of Diabetes and Digestive and Kidney Diseases

Weizmann Institute of Science

National Cancer Institute

Anil K. Kamaraju is an author at National Institutes of Health specializing in cell signaling, medicine, and signal transduction.

Top concepts

MedicineCell SignalingCell BiologySignal TransductionDiabetesInflammationGene ExpressionMetabolic SyndromeMetabolic SignalingMetabolic Regulation

Publications per year

2002–2011

9

Publications

9

Protection from Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling

Hariom Yadav, Celia Quijano, Anil K. Kamaraju et al. · Cell Metabolism · 2011 · 695 citations · Full text

Inflammation, Metabolic Syndrome, Obesity +12

Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton

Dalit Barkan, Hynda K. Kleinman, Justin L. Simmons et al. · Cancer Research · 2008 · 417 citations · Full text

Role of Rho/ROCK and p38 MAP Kinase Pathways in Transforming Growth Factor-β-mediated Smad-dependent Growth Inhibition of Human Breast Carcinoma Cells in Vivo

Anil K. Kamaraju, Anita B. Roberts · Journal of Biological Chemistry · 2004 · 224 citations · Full text

Transforming Growth Factor-β/Smad3 Signaling Regulates Insulin Gene Transcription and Pancreatic Islet β-Cell Function

Huei‐Min Lin, Ji-Hyeon Lee, Hariom Yadav et al. · Journal of Biological Chemistry · 2009 · 166 citations · Full text

Metabolic Syndrome, Insulin Signaling, Developmental Biology +14

Pax3 Down-regulation and Shut-off of Melanogenesis in Melanoma B16/F10.9 by Interleukin-6 Receptor Signaling

Anil K. Kamaraju, Corine Bertolotto, Judith Chebath et al. · Journal of Biological Chemistry · 2002 · 70 citations · Full text

Immunology, Melanoma B16/f10.9, Mitf Mrna +20

Rows per page

1–5 of 9